Bi-allelic inactivation of RB1 as a prognostic factor has not been described in myeloma before potentially for two reasons: homozygous deletion rates are low and the additional information provided by the identification of bi-allelic inactivation, through deletion and mutation, adds significantly to the prognostic information. Here, RB1 is linked to plasma cell myeloma.